International Paper Company (IP): Billionaire Dan Loeb Is Making Paper

Page 1 of 2

International Paper Company (NYSE:IP) saw a slight pull back earlier this month after posting weaker than expected earnings. First-quarter EPS came in at $0.65, $0.09 below consensus estimates. This will likely disappoint one of International Paper Company (NYSE:IP)’s largest shareholders, Third Point Capital and the hedge fund founder billionaire Dan Loeb. Loeb made the case for owning International Paper in his most recent letter to his investors dated April 10, 2013. In it he said:

International Paper Company (NYSE:IP) is a core position in our equity portfolio, which we sized up in the first quarter. IP has a compelling case for ownership buoyed by excellent sector and secular tailwinds.

With a current market capitalization of around $20 billion, IP is the largest player in the highlyconsolidated North American Containerboard (NACB) industry, which benefits from strong pricing power despite flat volumes due to nearly 100% operating rates…

IP has multiple near-term catalysts. The most immediate should come by the end of this month when the market learns if the industry’s latest price increase has been officially sanctioned. Proceeds from post-merger asset sales combined with IP’s robust pro forma cash flow should complete IP’s multi-year deleveraging, which has reduced debt by around $10 billion over the last four years. With a cleaner balance sheet and no opportunities for further acquisitions, we believe IP’s consistent cash flows will be returned increasingly to shareholders through buybacks and dividend increases. Even using stressed assumptions, IP should generate +$2.00 FCF per share, and we expect the dividend to rise to this level.

What impressed me the most from this letter is that Loeb is praising International Paper Company (NYSE:IP) and its CEO. Usually Loeb is bashing CEOs and angling for change. From the tone of this letter, he feels comfortable to sit back and let management do the work and make him money.

On the company’s earnings call, CEO John Faraci gave his assessment of IP as follows:

I just want to make sure investors understand this. IP is a cash flow story. We’re going to be approaching $2 billion of free cash flow in 2013. As we look at the year, we’re now over 4 months into it…we’re going to allocate that cash flow in a balanced way with a portion of it back to share owners.

Of the analysts that follow the stock, six have it rated as a Strong Buy, nine a Buy, and two a Hold. Price targets on the stock range from $51 to $60, with $54.50 being the median target, suggesting nearly 20% upside.

The industry

Some of the other major paper companies are also up nicely year to date. Packaging Corp Of America (NYSE:PKG) is up 24% year to date, while Clearwater Paper Corp (NYSE:CLW) is up 17%. Packaging Corp Of America (NYSE:PKG) is one of the largest producers of containerboard in the United States and also one of the largest manufacturers of corrugated packaging products.

Toward the end of last month, the company posted EPS of $0.62, compared to $0.42 for the same quarter last year, on the back of 12% higher sales year over year. Analysts expect Packaging Corp to grow revenue more than 11% in 2013 and then 4% in 2014. This should come on the back of a rebounding economy that boosts demand for corrugated packaging. The long-term prospects for Packaging Corp Of America (NYSE:PKG) are also robust, with analysts expecting the company to grow EPS at an annualized 15% over the next five years.

Clearwater Paper Corp (NYSE:CLW) produces pulp and paperboard at six facilities across the U.S. The company is a premier supplier of private label tissue to major retail grocery chains, and also produces bleached paperboard used by quality-conscious printers and packaging converters. Sales are expected to be up 5% in 2013 and 2014, with output from a new tissue machine boosting sales in 2013 thanks to a favorable product mix.

Demand for tissue should also expand along with a rebounding economy. This paper company posted EPS of $0.11 for the first quarter, compared to $0.42 for the same quarter last year and well below consensus of $0.57. Analysts are expecting 2013 EPS to be down by 10% from 2012; yet, analysts also expect the company to manage 15% annualized EPS growth over the next five years.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!